View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
FOLFOXIRI/BEVA5 - Bevacizumab 5 / Folinic Acid 200 / Fluorouracil 3200, Colorectal Carcinoma, Maintenance
Protocol-ID: 454 V1.2 (Mini), FOLFOXIRI/BEVA5 - BEVA5/CFOL200/FU3200, colorect. Ca, maint.Indication(s)
- Colon Cancer; ICD-10 C18.0, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C19
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 19.12.2023